Gene expression profiles of adipose tissue of obese rats after central administration of neuropeptide Y-Y5 receptor antisense oligodeoxynucleotides by cDNA microarrays

Peptides

Volumn 29, Issue 11, 2008, Pages 2052-2060

  Qiu, Jie ^a   Ni, Yu hui ^a   Chen, Rong hua ^a   Ji, Chen bo ^a   Liu, Feng ^a   Zhang, Chun mei ^a   Gao, Chun lin ^a   Chen, Xiao hui ^a   Tong, Mei ling ^a   Chi, Xia ^a   Zhou, Xiao yu ^a   Guo, Xi rong ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Adipose tissue; Antisense oligodeoxynucleotides; cDNA microarrays; Gene expression; Neuropeptide Y Y5 receptor; Obesity

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; COMPLEMENTARY DNA; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; NEUROPEPTIDE Y3 RECEPTOR; NEUROPEPTIDE Y4 RECEPTOR; NEUROPEPTIDE Y5 RECEPTOR;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; ENERGY METABOLISM; GENE CONTROL; GENE EXPRESSION; LIPID METABOLISM; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PRIORITY JOURNAL; RAT; UNINDEXED SEQUENCE;

ADIPOCYTES, WHITE; ADIPOSE TISSUE; ANIMALS; EATING; GENE EXPRESSION PROFILING; INSULIN; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OLIGONUCLEOTIDES, ANTISENSE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROPEPTIDE Y; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

RATTUS;

EID: 54049134394     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2008.06.024     Document Type: Article

References (33)

1. Agati J.M., Yeagley D., and Quinn P.G. Assessment of the roles of mitogen-activated protein kinase, phosphatidylinositol 3-kinase, protein kinase B, and protein kinase C in insulin inhibition of cAMP-induced phosphoenolpyruvate carboxykinase gene transcription. J Biol Chem 273 (1998) 18751-18759
2. Barre D.E. The role of consumption of alpha-linolenic, eicosapentaenoic and docosahexaenoic acids in human metabolic syndrome and type 2 diabetes-a mini-review. J Oleo Sci 56 (2007) 319-325
3. Cabrele C., Langer M., Bader R., Wieland H.A., Doods H.N., Zerbe O., et al. The first selective agonist for the neuropeptide YY5 receptor increases food intake in rats. J Biol Chem 275 (2000) 36043-36048
4. Campbell R.E., ffrench-Mullen J.M., Cowley M.A., Smith M.S., and Grove K.L. Hypothalamic circuitry of neuropeptide Y regulation of neuroendocrine function and food intake via the Y5 receptor subtype. Neuroendocrinology 74 (2001) 106-119
5. Cheatham B., Vlahos C.J., Cheatham L., Wang L., Blenis J., and Kahn C.R. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol Cell Biol 14 (1994) 4902-4911
6. Criscione L., Rigollier P., Batzl-Hartmann C., Rüeger H., Stricker-Krongrad A., Wyss P., et al. Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor. J Clin Invest 102 (1998) 2136-2145
7. Cross D.A., Alessi D.R., Cohen P., Andjelkovich M., and Hemmings B.A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378 (1995) 785-789
8. Dunaif A. Insulin action in the polycystic ovary syndrome. Endocrinol Metab Clin N Am 28 (1999) 341-359
9. Farley C., Cook J.A., Spar B.D., Austin T.M., and Kowalski T.J. Meal pattern analysis of diet-induced obesity in susceptible and resistant rats. Obes Res 11 (2003) 845e51
10. Gabbay R.A., Sutherland C., Gnudi L., Kahn B.B., O'Brien R.M., Granner D.K., et al. Insulin regulation of phosphoenolpyruvate carboxykinase gene expression does not require activation of the Ras/mitogen-activated protein kinase signaling pathway. J Biol Chem 271 (1996) 1890-1897
11. Gerald C., Walker M.W., Criscione L., Gustafson E.L., Batzl-Hartmann C., Smith K.E., et al. A receptor subtype involved in neuropeptide-Y-induced food intake. Nature 382 (1996) 168-171
12. Gong H.X., Guo X.R., Fei L., Guo M., Liu Q.Q., and Chen R.H. Lipolysis and apoptosis of adipocytes induced by neuropeptide Y-Y5 receptor antisense oligodeoxynucleotides in obese rats. Acta Pharmacol Sin 24 (2003) 569-575
13. Gregoire F.M., Smas C.M., and Sul H.S. Understanding adipocyte differentiation. Physiol Rev 78 (1998) 783-809
14. Hara K., Yonezawa K., Sakaue H., Ando A., Kotani K., Kitamura T., et al. 1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells. Proc Natl Acad Sci USA 91 (1994) 7415-7419
15. Hu Y., Bloomquist B.T., Cornfield L.J., DeCarr L.B., Flores-Riveros J.R., Friedman L., et al. Identification of a novel hypothalamic neuropeptide Y receptor associated with feeding behavior. J Biol Chem 271 (1996) 26315-26319
16. Inui A. Neuropeptide Y feeding receptors: are multiple subtypes involved?. Trends Pharmacol Sci 20 (1999) 43-46
17. Ishihara A., Kanatani A., Mashiko S., Tanaka T., Hidaka M., Gomori A., et al. A neuropeptide Y Y5 antagonist selectively ameliorates body weight gain and associated parameters in diet-induced obese mice. Proc Natl Acad Sci USA 103 (2006) 7154-7158
18. Jamshidi Y., Snieder H., Wang X., Pavitt M.J., Spector T.D., Carter N.D., et al. Phosphatidylinositol 3-kinase p85alpha regulatory subunit gene PIK3R1 haplotype is associated with body fat and serum leptin in a female twin population. Diabetologia 49 (2006) 2659-2667
19. Kahn C.R. Banting lecture. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 43 (1994) 1066-1084
20. Kalra P.S., and Kalra S.P. Use of antisense oligodeoxynucleotides to study the physiological functions of neuropeptide Y. Methods 22 (2000) 249-254
21. Kohgo Y., and Kato J. Role of apoptosis on morphogenesis and therapy in malignancy. Intern Med 37 (1998) 182-184
22. Levens N.R., and Della-Zuana O. Neuropeptide Y Y5 receptor antagonists as anti-obesity drugs. Curr Opin Investig Drugs 4 (2003) 1198-1204
23. Marsh D.J., Hollopeter G., Kafer K.E., and Palmiter R.D. Role of the Y5 neuropeptide Y receptor in feeding and obesity. Nat Med 4 (1998) 718-721
24. Montague C.T., and O'Rahilly S. The perils of portliness: causes and consequences of visceral adiposity. Diabetes 49 (2000) 883-888
25. Okada T., Kawano Y., Sakakibara T., Hazeki O., and Ui M. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes Studies with a selective inhibitor wortmannin. J Biol Chem 269 (1994) 3568-3573
26. Qian H., Hausman G.J., Compton M.M., Azain M.J., Hartzell D.L., and Baile C.A. Leptin regulation of peroxisome proliferator-activated receptor-gamma, tumor necrosis factor, and uncoupling protein-2 expression in adipose tissues. Biochem Biophys Res Commun 246 (1998) 660-667
27. Roberts C.K., Vaziri N.D., Liang K.H., and Barnard R.J. Reversibility of chronic experimental syndrome X by diet modification. Hypertension 37 (2001) 1323e8
28. Robinson L.E., Buchholz A.C., and Mazurak V.C. Inflammation, obesity, and fatty acid metabolism: influence of n-3 polyunsaturated fatty acids on factors contributing to metabolic syndrome. Appl Physiol Nutr Metab 32 (2007) 1008-1024
29. Salas-Salvadó J., Márquez-Sandoval F., and Bulló M. Conjugated linoleic acid intake in humans: a systematic review focusing on its effect on body composition, glucose, and lipid metabolism. Crit Rev Food Sci Nutr 46 (2006) 479-488
30. Schaffhauser A.O., Stricker-Krongrad A., Brunner L., Cumin F., Gerald C., Whitebread S., et al. Inhibition of food intake by neuropeptide Y Y5 receptor antisense oligodeoxynucleotides. Diabetes 46 (1997) 1792-1798
31. Tang-Christensen M., Kristensen P., Stidsen C.E., Brand C.L., and Larsen P.J. Central administration of Y5 receptor antisense decreases spontaneous food intake and attenuates feeding in response to exogenous neuropeptide Y. J Endocrinol 159 (1998) 307-312
32. Wieland H.A., Hamilton B.S., Krist B., and Doods H.N. The role of NPY in metabolic homeostasis: implications for obesity therapy. Expert Opin Investig Drugs 9 (2000) 1327-1346
33. Zemel M.B. Nutritional and endocrine modulation of intracellular calcium: implications in obesity, insulin resistance and hypertension. Mol Cell Biochem 188 (1998) 129-136